Rewiring of Integrin Signaling and Cell-cycle Deregulation Drive SMARCB1-Deficient Epithelioid Sarcoma
Ryo Miyamoto, Jiyeon Park, Gabrielle H Dwosh, Valentina Zuco, Sandro Pasquali, Brendan Craig Dickson, David G. Kirsch
This study identifies integrin signaling and cell-cycle deregulation as key drivers of SMARCB1-deficient epithelioid sarcoma and highlights therapeutic targets.
bioRxiv · Sep 3, 2026 · PreprintCancer Biology